4nsk: Difference between revisions

Revision as of 15:04, 1 January 2014

CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE ligand V3PCRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE ligand V3P

FunctionFunction

[HA11_MOUSE] Involved in the presentation of foreign antigens to the immune system. [B2MG_MOUSE] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system.

About this StructureAbout this Structure

4nsk is a 3 chain structure. This structure supersedes the now removed PDB entry 3tbx. Full crystallographic information is available from OCA.

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
+{{STRUCTURE_4nsk|  PDB=4nsk  |  SCENE=  }}
+===CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE ligand V3P===
-The entry 4nsk is ON HOLD
+==Function==
+[[http://www.uniprot.org/uniprot/HA11_MOUSE HA11_MOUSE]] Involved in the presentation of foreign antigens to the immune system. [[http://www.uniprot.org/uniprot/B2MG_MOUSE B2MG_MOUSE]] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system.
-Authors: Allerbring, E.B., Duru, A.D., Uchtenhagen, H., Mazumdar, P.A., Badia-Martinez, D., Madhurantakam, C., Sandalova, T., Nygren, P., Achour, A.
+==About this Structure==
+[[4nsk]] is a 3 chain structure. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=3tbx 3tbx]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NSK OCA].
-Description: CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE ligand V3P
+[[Category: Achour, A.]]
+[[Category: Allerbring, E B.]]
+[[Category: Badia-Martinez, D.]]
+[[Category: Duru, A D.]]
+[[Category: Madhurantakam, C.]]
+[[Category: Mazumdar, P A.]]
+[[Category: Nygren, P.]]
+[[Category: Sandalova, T.]]
+[[Category: Uchtenhagen, H.]]
+[[Category: Agonism]]
+[[Category: Altered peptide ligand]]
+[[Category: Antagonism]]
+[[Category: Antigen presentation]]
+[[Category: Beta2-microglobulin]]
+[[Category: Cd8]]
+[[Category: Cell surface]]
+[[Category: Immune system]]
+[[Category: Immune system-peptide complex]]
+[[Category: Lcmv]]
+[[Category: Murine mhc]]
+[[Category: Receptor binding]]
+[[Category: T cell receptor]]
+[[Category: T cell recognition]]